Aspen Pharmacare: Unhealthy Price Action, But Flashing For Opportunity
- Lester Davids
- Oct 23, 2024
- 1 min read
Wednesday 23 October 2024
Time Published: Pre-Market
Ticker: APN
I am fully aware of the heavy selling pressure and poor price action, however, I am starting to notice readings coming through which states that the reward-to-risk is becoming attractive for a small buy/long position.
While the readings are there, it may just be sensible to wait until the price stops going down and starts to form a base...or gives us a 'flush low' and a V-shaped reversal setup.
Notice the 5 to 8 week reading also stating that selling is aggressive and that we should wait for the price to stabilize?
I drew these lines a few weeks ago, thinking R160 or thereabout would be a level of interest.
Previous Post: Aspen Pharmacare: The Long and Short of It - Thursday, 05 September 2024
Pre-Market
Ticker: APN
Within the span of 19 months, the share has provided clients of Unum Capital with two opportunities to profit.
These opportunities came on both the long (buy) and short (sell) side, benefiting from a rising and falling share price.
The short leg provided short term traders with 3x opportunities to sell above 23500c.
Although the share briefly test the stop-loss level (a spike), the share pullback was in line with the view.
The updated chart, with the time-stamped ideas, is shown below.
Lester Davids
Analyst: Unum Capital
Comments